|
Welcome to datamethods
|
|
1
|
4856
|
July 24, 2018
|
|
Statistically Efficient Ways to Quantify Added Predictive Value of New Measurements
|
|
28
|
3000
|
November 27, 2020
|
|
Collider bias in obesity research
|
|
0
|
35
|
November 27, 2020
|
|
Pre/post and Longitudinal model when there is no expectation of equal means at baseline
|
|
2
|
84
|
November 25, 2020
|
|
Covid-19 vaccine Phase 3 trials
|
|
2
|
149
|
November 25, 2020
|
|
Why not use the inverse logit transformation to get fitted risks (probabilities) in epi?
|
|
6
|
226
|
November 25, 2020
|
|
Calibration of Cox model
|
|
15
|
2107
|
November 23, 2020
|
|
Even small (clinically insignificant) effects matter, if we expose a lot of people to them
|
|
17
|
1933
|
November 22, 2020
|
|
Multiple enrollement of same patient and cox analysis, problem?
|
|
8
|
171
|
November 21, 2020
|
|
Parametric survival models for prediction and non-proportional hazards
|
|
6
|
224
|
November 21, 2020
|
|
Randomized trial with variation around pre-specified follow-up times
|
|
4
|
182
|
November 20, 2020
|
|
Seeking guidance on estimating variance of a given model
|
|
2
|
118
|
November 19, 2020
|
|
Likelihood ratio is a ratio of odds (but not the usual odds ratio)
|
|
7
|
254
|
November 18, 2020
|
|
What would get Stan more use in FDA IND applications?
|
|
14
|
568
|
November 18, 2020
|
|
Quality of remdesivir trials
|
|
41
|
1713
|
November 18, 2020
|
|
Is the interaction between Clinical Researchers and Statisticians working? My insight after reading four failed clinical trials on immunotherapy
|
|
56
|
5858
|
July 25, 2020
|
|
Landmark analysis with a variable landmark time
|
|
2
|
166
|
November 14, 2020
|
|
Sample size estimation
|
|
6
|
229
|
November 14, 2020
|
|
Robust vs Bootstrap standard errors for logistic regression model
|
|
2
|
260
|
November 14, 2020
|
|
Beta-binomial distributions using BRMS in R - How should I use the custom_family argument?
|
|
0
|
87
|
November 11, 2020
|
|
Multi-state AFT Regression
|
|
0
|
98
|
November 10, 2020
|
|
Proper analysis and presentation of the association between a continuous exposure and a binary outcome
|
|
1
|
204
|
November 8, 2020
|
|
Just a simple Q: Why the interval between upper & lower limit and mean differ?
|
|
1
|
180
|
November 2, 2020
|
|
Using p-values, S-values, and the Bayesian Rejection Ratio to re-examine a meta-analysis on knee abduction kinematics and ACL injury risk
|
|
2
|
411
|
November 1, 2020
|
|
"Competing risk" which increases probability of outcome
|
|
3
|
257
|
October 31, 2020
|
|
Length of hospitalization in clinical trials
|
|
4
|
324
|
October 30, 2020
|
|
Percent change in bone mineral density (BMD) as a surrogate endpoint for fractures
|
|
1
|
218
|
October 29, 2020
|
|
Sensitively and specificity
|
|
2
|
244
|
October 27, 2020
|
|
How interactions impact trial reporting
|
|
2
|
300
|
October 27, 2020
|
|
RMS Discussions
|
|
124
|
7794
|
October 26, 2020
|
